Related Experiment Video
Updated: Jun 20, 2025
09:26
DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation
Published on: December 29, 2021
4.2K
DNA Logical Computing on a Transistor for Cancer Molecular Diagnosis
Derong Kong1,2, Shen Zhang1,2, Xinye Ma1,2
1State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Shanghai, 200433, P. R. China.
Angewandte Chemie (International Ed. in English)
|July 22, 2024
Summary
A new transistor-based DNA molecular computing platform enables simultaneous detection and logical analysis of multiple microRNA markers for cancer diagnostics. This technology offers high accuracy and sensitivity for point-of-care personalized medicine.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Nanotechnology
Background:
- Cancer diagnosis requires precise monitoring of nucleic acid markers, but current methods are costly and complex.
- Existing molecular diagnostics struggle with multi-marker analysis and point-of-care applications.
Purpose of the Study:
- To develop a transistor-based platform for simultaneous detection and logical analysis of multiple microRNA markers.
- To enable high-accuracy, point-of-care cancer diagnostics with immediate results.
Main Methods:
- Demonstration of a transistor-based DNA molecular computing (TDMC) platform.
- Utilizing TDMC for simultaneous detection and logical analysis of microRNA markers on a single transistor.
- Performing basic and complex cascading logical operations for multi-index analysis.
Main Results:
- TDMC enables simultaneous detection and logical analysis of multiple microRNA markers.
- Achieved ultrasensitive detection down to 2×10-16 M concentration.
- Demonstrated 98.4% accuracy in diagnosing hepatocellular carcinoma from serum samples.
Conclusions:
- TDMC platform offers efficient, accurate, and sensitive multi-analyte detection and computation.
- This technology provides a foundation for "one-stop" personalized cancer medicine.
- TDMC represents a significant advancement in point-of-care molecular diagnostics.
